Eiko Lifesciences Ltd vs Sree Rayalaseema Hi Strength Hypo Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 24, 2026

Key Highlights

The Latest Trading Price of Eiko Lifesciences Ltd is ₹ 48.5 as of 24 Mar 16:01 . The P/E Ratio of Eiko Lifesciences Ltd changed from 31.1 on March 2025 to 31.1 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Sree Rayalaseema Hi-Strength Hypo Ltd changed from 6.7 on March 2021 to 9.4 on March 2025 . This represents a CAGR of 7.01% over 5 years The Market Cap of Eiko Lifesciences Ltd changed from ₹ 65.15 crore on March 2025 to ₹ 65.15 crore on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Sree Rayalaseema Hi-Strength Hypo Ltd changed from ₹ 405.69 crore on March 2021 to ₹ 845.2 crore on March 2025 . This represents a CAGR of 15.81% over 5 years The revenue of Eiko Lifesciences Ltd for the Dec '25 is ₹ 12.33 crore as compare to the Sep '25 revenue of ₹ 11.97 crore. This represent the growth of 3.01% The revenue of Sree Rayalaseema Hi-Strength Hypo Ltd for the Dec '25 is ₹ 160.58 crore as compare to the Sep '25 revenue of ₹ 189.49 crore. This represent the decline of -15.26% The ebitda of Eiko Lifesciences Ltd for the Dec '25 is ₹ 2.22 crore as compare to the Sep '25 ebitda of ₹ 2.07 crore. This represent the growth of 7.25% The ebitda of Sree Rayalaseema Hi-Strength Hypo Ltd for the Dec '25 is ₹ 36.45 crore as compare to the Sep '25 ebitda of ₹ 34.05 crore. This represent the growth of 7.05% The net profit of Eiko Lifesciences Ltd changed from ₹ 0.35 crore to ₹ 1.43 crore over 7 quarters. This represents a CAGR of 123.51% The net profit of Sree Rayalaseema Hi-Strength Hypo Ltd changed from ₹ 18.62 crore to ₹ 23.75 crore over 7 quarters. This represents a CAGR of 14.92% The Dividend Payout of Eiko Lifesciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sree Rayalaseema Hi-Strength Hypo Ltd changed from 8.5 % on March 2021 to 5.55 % on March 2025 . This represents a CAGR of -8.17% over 5 years .

About Eiko Lifesciences Ltd

Eiko Lifesciences Limited was originally incorporated on January 07, 1977, under the name Narendra Investments (Delhi) Limited.
Later, the Company changed its name from Narendra Investments (Delhi) Limited to Eiko LifeSciences Limited effective from June 24, 2021.
Earlier, the Company engaged in sale and purchase of shares and securities.
At present, the Company is a leading manufacturer, supplier and exporter of Speciality Chemicals and Pharma Intermediates in India and globally. The Company commenced new business activity primarily in manufacturing of speciality and fine chemicals in October, 2020 from manufacturing facility located at Badlapur, Maharashtra and has since scaled its operations, grown brand and customer base to become the one of the fastest growing speciality chemicals companies in India.

About Sree Rayalaseema Hi-Strength Hypo Ltd

Sree Rayalaseema Hi-Strength Hypo Limited was incorporated in March, 2005.
The Company is the leading producer of Calcium Hypo Chloride, Stable Bleaching Powder, Sulphuric Acid and Other Chemicals. Sree Rayalaseema Hi-Strength Hypo, the torch bearer of the conglomerate, is the only Indian manufacturer of Calcium Hypochlorite, and one of the very few in the world.
A state-of-the-art sodium process technology developed through in-house R&D efforts helps the company in manufacturing the product with a chlorine content of 65% to 70%. The business of manufacturing of industrial chemicals was vested in the Company effective on 1st April, 2005 through Scheme of Arrangement in June, 2006 and generation of Wind Energy in 2008. The Company products can be broadly classified under Inorganic chemicals.

FAQs for the comparison of Eiko Lifesciences Ltd and Sree Rayalaseema Hi-Strength Hypo Ltd

Which company has a larger market capitalization, Eiko Lifesciences Ltd or Sree Rayalaseema Hi-Strength Hypo Ltd?

Market cap of Eiko Lifesciences Ltd is 71 Cr while Market cap of Sree Rayalaseema Hi-Strength Hypo Ltd is 711 Cr

What are the key factors driving the stock performance of Eiko Lifesciences Ltd and Sree Rayalaseema Hi-Strength Hypo Ltd?

The stock performance of Eiko Lifesciences Ltd and Sree Rayalaseema Hi-Strength Hypo Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Eiko Lifesciences Ltd and Sree Rayalaseema Hi-Strength Hypo Ltd?

As of March 24, 2026, the Eiko Lifesciences Ltd stock price is INR ₹50.1. On the other hand, Sree Rayalaseema Hi-Strength Hypo Ltd stock price is INR ₹414.7.

How do dividend payouts of Eiko Lifesciences Ltd and Sree Rayalaseema Hi-Strength Hypo Ltd compare?

To compare the dividend payouts of Eiko Lifesciences Ltd and Sree Rayalaseema Hi-Strength Hypo Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.